Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose trivalent inactivated influenza vaccine in older adults in Korea
KCT0012644Phase 4Not yet recruiting
- Sponsor
- Sanofi
- Start
- Sep 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (quadrivalent, high-dose), influenza vaccine in influenza, sponsored by Sanofi. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
influenza vaccine (quadrivalent, high-dose)influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on KCT0012644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012644.